Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements
Guidance on applications for COVID-19 drug clinical trials under the Regulations: Post-authorization requirements is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2023-10-28. On CanQuery you can follow the original downloads. Files are available in English and French.
This section of the guidance outlines requirements for the licence holder after authorization of the clinical trials.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-10-28
Data overview
- Formats
- HTML
- File languages
- English, French